CCO Treatment Updates
Optimizing Treatment Choices in Ovarian Cancer
Virtual Presentations
Early Detection and Treatment of Ovarian Cancer
|
|
|
Judith K. Wolf, MD, discusses risk factors, screening strategies, and prophylactic surgery in the setting of ovarian cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Cite risk factors associated with prognosis in patients with ovarian cancer
- Discuss screening strategies for ovarian cancer patients
- Explain the risks and benefits of prophylactic surgery in the setting of ovarian cancer
|
Slideset: The Importance of Early Detection and Treatment of Ovarian Cancer
 |
|
Downloadable slidesets including how to identify risk factors, as well as screening and prevention strategies for ovarian cancer patients.
Format: Microsoft PowerPoint (.ppt) |
File size: 674 KB
| Date posted: 3/17/2008
|
Current Controversies in the Management of Recurrent Ovarian Cancer
|
|
|
Robert F. Ozols, MD, PhD, discusses current clinical management strategies for patients with recurrent ovarian cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Define the magnitude of the clinical issue of recurrent ovarian cancer
- Discuss the use of chemotherapy for the treatment of patients with platinum-sensitive recurrent ovarian cancer
- Explain therapeutic strategies under investigation for the treatment of patients with platinum-resistant ovarian cancer
|
Slideset: Current Controversies in the Management of Recurrent Ovarian Cancer
 |
|
Downloadable slidesets on controversial topics and treatment approaches for managing recurrent ovarian cancer patients
Format: Microsoft PowerPoint (.ppt) |
File size: 410 KB
| Date posted: 4/29/2008
|
New Agents for the Management of Ovarian Cancer
|
|
|
Bradley J. Monk, MD, discusses new agents and strategies for the clinical management of patients with ovarian cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss results of recent clinical trials of monoclonal antibodies used in the clinical management of ovarian cancer
- Describe novel agents used in the treatment of patients with ovarian cancer
- Cite clinical trials comparing novel agents with standard chemotherapies used in the clinical management of patients with ovarian cancer
|
Slideset: New Agents for the Management of Ovarian Cancer
 |
|
Downloadable slidesets on new agents in development for recurrent ovarian cancer patients
Format: Microsoft PowerPoint (.ppt) |
File size: 2.05 MB
| Date posted: 5/2/2008
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|